Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 131Sexual function and dysfunction studiesUrological Disorders and TreatmentsUrinary Bladder and Prostate Research

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Double–Blind, Crossover Comparison of 3 mg Apomorphine SL with Placebo and with 4 mg Apomorphine SL in Male Erectile Dysfunction

Abstract

Objective To establish the efficacy and safety of a fixed, 3-mg dose of apomorphine SL compared with placebo, and to compare 3 mg with 4 mg apomorphine SL in patients with erectile dysfunction. Methods This randomized, double-blind, crossover study included 296 heterosexual men with ED of various etiologies and severities. Two crossover groups were evaluated separately: 3 mg apomorphine SL vs. placebo (n = 194), and 3 vs. 4 mg apomorphine SL (n = 102). The primary efficacy variable was the percentage of attempts resulting in erections firm enough for intercourse; additional variables included the percentage of attempts resulting in intercourse and time to erection. Partner assessments were also analyzed. Results 3 mg apomorphine SL was significantly more effective than placebo (p Conclusions 3 mg apomorphine SL was significantly more effective than placebo and comparable to 4 mg, while offering an improved risk-benefit ratio.

Overview

Integrity signals

Registry

Crossref · 10.1159/000052503

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 131

Metadata

Authors
Dula, E., Bukofzer, S., Perdok, R., & George, M.
Affiliations
  • Abbott (United States) (US)
  • Takeda (United Kingdom) (GB)
Venue
European Urology
Publisher
Elsevier BV
Published
2001
Volume
39
Issue
5
Pages
558-564
ISSN
  • 0302-2838 (ISSN-L)
  • 1421-993X
OpenAlex
W2036887714
Cited by
131
References
12
Citations by year
2025: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 4
FWCI
14.73
Type
journal article
Language
en
Open access
closed
Locations
  • European Urology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
apomorphine, erectile dysfunction, sublingual administration, dose comparison, placebo comparison, nausea, adverse events, risk-benefit ratio
MeSH terms
Administration, Sublingual, Adult, Aged, Apomorphine, Coitus, Double-Blind Method, Humans, Erectile Dysfunction, Male, Middle Aged, Dopamine Agonists, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.